Received grant in 2019
DCCC has funded 171,000 DKK to the project.
Taxane-based therapies are integral to the treatment of breast cancer. Chemotherapy-induced peripheral neuropathy (CIPN) is a common, disabling and dose-limiting side effect of these agents. CIPN adversely affect survival and quality of life. It presents as a distal sensory neuropathy, including pain, numbness and tingling in hands/feet. Symptoms may improve but for some patients it is permanent. No established strategy exists for CIPN management.
The funds will be used to start a trial to study the efficacy of frozen gloves and socks to prevent paclitaxel chemotherapy induced peripheral neuropathy.
Multidisciplinary organisation
DBCG – Danish Breast Cancer Group
Project stakeholders
- Maria Elisabeth Lendorf, MD, PhD, Department of Oncology, Rigshospitalet. Primary contact, mail: maria.elisabeth.lendorf.02@regionh.dk
- Ann Knop, Consultant, PhD, Department of Oncology, Rigshospitalet
- Hella Danø, Consultant, PhD, Department of Oncology and Palliation, North Zealand Hospital
- Anders Bonde Jensen, Professor, Consultant, PhD, Department of Cancer, Aarhus University Hospital